Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease

Am Heart J. 1997 Nov;134(5 Pt 2):S88-96.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Drug Costs
  • Fibrinolytic Agents / economics*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Myocardial Ischemia / drug therapy*

Substances

  • Fibrinolytic Agents